large protein molecule
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Rheumatoid Arthritis
Conditions
Rheumatoid Arthritis
Trial Timeline
Jul 1, 2006 → Oct 1, 2006
NCT ID
NCT00369187About large protein molecule
large protein molecule is a approved stage product being developed by Halozyme Therapeutics for Rheumatoid Arthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT00369187. Target conditions include Rheumatoid Arthritis.
What happened to similar drugs?
20 of 20 similar drugs in Rheumatoid Arthritis were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00369187 | Approved | Completed |
Competing Products
20 competing products in Rheumatoid Arthritis